Shopping Cart
- Remove All
Your shopping cart is currently empty
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $698 | 10-14 weeks | |
| 5 mg | $1,470 | 10-14 weeks | |
| 10 mg | $1,990 | 10-14 weeks | |
| 25 mg | $2,950 | 10-14 weeks | |
| 50 mg | $3,980 | 10-14 weeks | |
| 100 mg | $5,378 | 10-14 weeks |
| Description | DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect. |
| Synonyms | DRX065, DRX 065, deuterated R-enantiomer of pioglitazone |
| Molecular Weight | 357.45 |
| Formula | C19H20N2O3S |
| Cas No. | 1259828-75-5 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.